NIH-funded research R01 grant

How FGF signaling affects lung development and alveolar formation

Official title: Regulation of primary and secondary alveologenesis by FGF signaling pathways

Funded at Washington University · NIH-11028111 · Data updated 2026-11-12

This study is looking at how certain signals in the body help form tiny air sacs in the lungs, which are really important for breathing, especially in premature babies who might have trouble with their lungs due to a condition called bronchopulmonary dysplasia (BPD), and it hopes to find new ways to help these babies breathe better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJanuary 29, 2025
Project endNovember 30, 2028
Funding year2025
Award (this year)$740,317
NIH project number1R01HL176901-01
Project IDNIH-11028111 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants diagnosed with bronchopulmonary dysplasia who are experiencing impaired lung development.

Less likely to help

Patients who are not premature or do not have bronchopulmonary dysplasia may not benefit from this research.

What this research studies

This research investigates the role of FGF signaling pathways in the development of alveoli, which are crucial for effective lung function. It focuses on understanding how these pathways influence the formation of alveolar structures during lung development, particularly in the context of bronchopulmonary dysplasia (BPD), a condition that affects premature infants. By studying the cellular and molecular mechanisms involved, the research aims to identify potential therapeutic targets to enhance lung development and improve outcomes for affected infants.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that promote lung development in infants with bronchopulmonary dysplasia, potentially reducing long-term respiratory issues.

How similar studies have gone: Previous research has shown promising results in understanding lung development mechanisms, but this specific approach focusing on FGF signaling pathways is relatively novel.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Ornitz, David M — Washington University
  • Study coordinator: Ornitz, David M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.